ALBERTDAVD logo

Albert David

(NSE: ALBERTDAVD)

ALBERTDAVD

563.35

0.00 (0.00%)

Albert David Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Albert David Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Albert David Price Summary

Today’s High

578.9

Today’s Low

562.35

52 Week's High

578.9

52 Week's Low

562.35

Albert David Fundamentals

Market Cap

326.7 Cr

CASA

0.0

No. Of Shares

57.07 L

P/E

9.7

P/B

0.9

Face Value

10.0

Dividend Yeild

1.6

Book Value

428.2

Net Interest Income

316.5

Cost to Income

NA

Promoter Holdings

62.0

EPS

38.8

CAR

NA

ROE

9.5

ROCE

12.0

Profit Growth

NA

Albert David Peer Comparison

COMPANY

PRICE

MCAP (cr)

P/B

P/E

EPS

ROE

ROCE

NII

Albert David

563.35

326.7 Cr

0.9

9.7

38.8

9.5

12.0

316.5

Krebs Biochem

114.5

323.4 Cr

-3.7

0.0

-14.5

0.0

-44.3

7.2

Ind-Swift Labs

58.45

352.5 Cr

1.0

0.0

-0.7

-1.0

8.2

51.3

Kilitch Drugs

170.9

300.0 Cr

0.8

20.4

4.0

3.9

4.9

177.3

Venus Remedies

214.35

385.9 Cr

0.9

6.2

44.0

15.1

10.8

12.2

Wanbury

65.75

256.4 Cr

-1.6

0.0

-5.0

0.0

46.9

40.2

FAQ’s on Albert David

About Albert David

Albert David was incorporated in the year 1938. The company is a part of Kothari group.

Albert David, which has decades of illustrious presence in the health care industry, manufactures pharmaceutical formulations and bulk drugs, infusion solutions and oral solids, disposable syringes and needles and herbal formulations. The company exports these products to Vietnam, Russia, Belarus, Egypt, Bangladesh, Kenya, Tanzania, Uganda, Sudan, Ethiopia, Nigeria, Zaire, Haiti, Brazil, Canada, USA, UK, Netherlands and Germany as the company is a WHO-approved supplier.

It also has DMF for the bulk drugs, Tolbutamide and Chlorpropamide with the US Food and Drugs Administration (USFDA). The manufacturing facility for these products has been inspected and validated by the US drug regulator.

The manufacturing plants of the company are located at Ghaziabad near New Delhi, Kolkata and Mandideep near Bhopal.

The company`s amino acid range under the brand name of Alamin contains pure crystalline amino acid of high international standards manufactured under a unique technology, which conforms to WHO and FAO recommendations. In the herbal segment, the company sells its products under brand names like Adliv, which is a hepato protective and Siotone capsule, which is the only adaptogen indicated for stress.

ADL has tie-ups with Ajinomoto Co and Roussel Morishita Co of Japan for manufacturing and marketing a wide range of crystalline amino acid infusion solutions, oral solids and liquids in India.

Products offered by the Company:

The company is operating in major therapeutic segments that include:

  • Analgesics/AntiInflammatory
  • Anti-Bacterials
  •  Anti-Ulcerants
  •  Dermatologicals
  • Anxiolytics
  • Large Volume Parenteral
  •  Disposable Syringes & Needles
  • Herbal Drugs
  • Nutrition
  • Neurotropics
  •  Placental Extracts
  •  Anthelmintic
  • Haemostati
  • Cough Preparations
  • Laxatives
  • Skeletal Relaxants
  • Anti-Arthiritic / Chondroprotective Agents.

Future Plans:

  • The company will explore the possibilities for export of its IV fluids, small volume parenterals and disposable syringes in addition to its existing range.
  • It will concentrate on product line extension for its flagship brand Placentrex by bringing in newer formulations and looking for a new therapeutic area of usage.
  •  Future expansion in the herbal product range will be focused in the area of women`s healthcare.
  • ADL is planning to enter newer therapeutic areas like dermatological and ophthalmological segments.
  • Furthermore, it will also strengthen its presence in the gastrointestinal segments and in the areas of pain management.
  •  The company is also planning to launch newer products in the areas of nutritional, gynaecological and herbal medicine.

Trade Albert David today

Create a free portfolio in Trinkerr and earn and grow along with peers